Paving the way for type 2 diabetes prevention treatments 8 February 2019 Insulin resistance is the process where the body stops responding to insulin like it should. It can lead to type 2 diabetes. Researchers hope that a better understanding of the process of insulin resistance could pave the way for new treatments to help prevent the condition. With the help of a Diabetes Australia Research Trust grant Dr James Krycer from the University of Sydney is studying the way glucose is processed in the body and believes that could help us better understand insulin resistance. “Most studies of insulin resistance look at how glucose is transported into tissues within the body after it is consumed in a meal, however we have exciting data that suggests the way glucose is processed within tissues may be just as important,” Dr Krycer said. “Using a new technique known as metabolomics we are able to see how the body processes glucose whether that is burning it for energy or storing it away in the form of fat or glycogen. “Understanding how this change during insulin resistance can help us develop targeted strategies that improve the way the body processes glucose.” Find out how you can support research like Dr Krycer’s here.
Media releases 8 July 2026 Territory-led digital health innovation receives boost from national partnership A major funding boost will expand digital health solutions for complex care in the Northern Territory (NT), thanks to a joint investment from Diabetes Australia and Lilly Australia, in partnership with Menzies School of Health Research (Menzies). Continue Reading
Blog 8 July 2026 Taking the community’s voice to a global stage: IDF Western Pacific Region Congress 2026 This National Diabetes Week, we’re looking ahead to a landmark moment for our community, one that will see the voices,... Continue Reading
Media releases 18 June 2026 Hope for Australians living with cystic fibrosis and diabetes as new research targets breakthrough treatment A leading diabetes and respiratory researcher is investigating whether a breakthrough cystic fibrosis treatment could change the course of a serious form of diabetes affecting Australians living with cystic fibrosis. Continue Reading